Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
News, views, and coverage of important topics and discussions from oncology conferences and events.
[widgetkit id="1" name="CC Event Nav"]
ACR 2017
,
Conference Correspondent
Active Treatment Leads to Improved Myocardial Function in Patients with Active RA
Read More
ASCO 2020 - Lung Cancer
ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC
Read More
Conference Correspondent
Adding Abatacept to the Euro-Lupus Nepthritis Regimen in Patients with Lupus Nephritis: Results from ACCESS, a 24-Week, Double-Blind Controlled Trial
Read More
ASH 2017 - Chronic Lymphocytic Leukemia
Adverse Events, Resource Use, and Economic Burden in Patients with Mantle-Cell Lymphoma in the United States
Read More
ASH 2019 - Chronic Lymphocytic Leukemia
Alliance A041702 Phase 3 Study Comparing Ibrutinib + Obinutuzumab versus Ibrutinib + Venetoclax + Obinutuzumab in Untreated, Older Patients with CLL
Read More
ASCO 2017 - Acute Myeloid Leukemia
Allogeneic Transplant Leads to Markedly Improved Survival in Older Patients with Acute Myeloid Leukemia
Read More
ACR 2017
,
Conference Correspondent
An Updated Integrated Safety Analysis of Baricitinib for the Treatment of Moderate-to-Severe RA
Read More
IDWeek 2018
Antimicrobial Stewardship Program Aims to Reduce Antimicrobial Usage in Geriatric Patients without Affecting Outcomes
Read More
ASCO 2020 - Lung Cancer
ASCO 2020 Lung Cancer Highlights
Read More
ASCO 2017 - Acute Myeloid Leukemia
Assessment of Molecular Response to Gilteritinib in FLT3 Mutation–Positive Relapsed/Refractory Acute Myeloid Leukemia
Read More
1
2
3
4
5
6
Page 3 of 25
Results 21 - 30 of 242